Life Sciences Multi Vendor Renewal. A program case study.

A life sciences enterprise turned four overlapping vendor renewals into a single sequenced program, working around the GxP validation constraint to recover spend without disrupting validated systems.

What did the life sciences renewal program face?

The enterprise ran a regulated estate with four major vendor agreements maturing inside 18 months. Oracle, SAP, Microsoft, and ServiceNow renewals overlapped, and each account team negotiated as if it were the only one in the room.

The complication was regulatory. Core systems were validated under Good Practice (GxP) rules, so they could not be re architected or migrated quickly to create negotiation leverage.

Validated systems in life sciences are governed by frameworks such as the principles behind the FDA guidance on computerized systems. That validation burden is real and shaped the entire program.

The validated systems constraint (GxP)

A validated system carries documented evidence that it works as intended. Changing it means revalidation, which is slow and costly. That reality removed migration as a credible near term threat against the incumbents.

• Revalidation cost: migration triggers a full validation cycle, measured in months.
• Audit exposure: regulators expect continuity and documented control.
• Timeline rigidity: changes follow the validation calendar, not the sales quarter.

Sequencing Oracle, SAP, Microsoft, and ServiceNow

With migration off the table short term, sequencing became the lever. The team ordered the renewals so the most flexible vendor closed first and set a reference point for the rest.

How did the multi vendor renewal sequence work?

The program ran as one coordinated calendar rather than four separate events. A single team held the entitlement evidence, the benchmarks, and the negotiation plan across all four vendors.

Each renewal informed the next. Terms won from the first vendor became the benchmark presented to the others, which compressed the negotiation cycle and the discounting argument.

Where the common advice on multi vendor renewals is wrong

The standard advice is to negotiate each vendor separately so each account team competes hardest for its own deal. We disagree. In roughly two thirds of the regulated estates we advised in 2024 and 2025, the separate negotiation approach left 8 to 18 percent on the table because the buyer never built a portfolio view or a shared evidence base. The buyer side move is to run the renewals as one program with one team, one set of entitlement records, and a sequence that lets each closed deal set the benchmark for the next. Vendors negotiate hardest against a buyer who can show what the last vendor agreed to.

In a regulated estate the validation calendar is not only a constraint. Framed as a fixed and defensible timeline, it becomes leverage.

What results did the renewal program deliver?

The program delivered double digit percentage savings across the portfolio while keeping every validated system in continuous compliance. No system was disrupted to chase a discount.

• Portfolio saving: 14 percent across the four agreements combined.
• Zero disruption: no validated system was migrated or revalidated under pressure.
• Faster cycles: later renewals closed faster against the established benchmark.

The compliance evidence that anchored each negotiation

Clean entitlement and deployment records were the strongest asset. For Oracle the certification and contract evidence blunted audit pressure, and SAP's published agreement and licensing terms framed the indirect access discussion. Microsoft's licensing documentation grounded the SKU rightsizing, and a ServiceNow active user audit cut subscription creep.

Savings by vendor

Savings were uneven by design. The most over provisioned agreements gave back the most, while the leanest gave back the least. The portfolio number mattered more than any single line.

What buyer side lessons transfer to other estates?

The lessons transfer to any enterprise with overlapping renewals, regulated or not. Coordinate, build evidence, and sequence deliberately.

1. Run a program: coordinate overlapping renewals as one calendar.
2. Hold the evidence: centralize entitlement and deployment records.
3. Sequence on purpose: let the most flexible vendor set the benchmark.
4. Reframe constraints: a fixed compliance timeline can be leverage.

What we would do differently

Earlier evidence gathering would have helped. The team built the entitlement records during the program rather than before it, which delayed the first negotiation. Start the evidence base 6 to 9 months before the first renewal.

What to do next

1. Map every vendor agreement maturing in the next 18 to 24 months onto one calendar.
2. Identify which systems are validated or otherwise hard to migrate, and which are flexible.
3. Centralize entitlement and deployment evidence for every in scope vendor.
4. Sequence the renewals so the most flexible vendor closes first and sets a benchmark.
5. Carry each closed deal's terms into the next negotiation as the reference point.
6. Frame fixed compliance timelines as defensible constraints, not as weaknesses.
7. Begin the evidence base 6 to 9 months before the first renewal, not during it.

White Paper · Multi Vendor

Build Multi Cloud Leverage: 5 Buyer Side Moves

The buyer side multi cloud leverage strategy: AWS, Azure, and Google Cloud commitment dynamics, plus the Oracle Cloud workload portability framework. Read it free.

Read the white paper

Frequently asked questions

What is a multi vendor renewal program?

A multi vendor renewal program coordinates several overlapping software renewals into one sequenced plan run by a single team. Instead of negotiating each vendor separately, the buyer builds a portfolio view and a shared evidence base to improve terms across all of them.

Why does the GxP validation constraint matter in life sciences?

Validated GxP systems carry documented evidence that they work as intended, so changing them requires costly revalidation. This removes migration as a near term negotiation threat, but a fixed validation timeline can be reframed as defensible leverage.

How much did the program save?

The program delivered roughly 14 percent in savings across the four combined agreements while keeping every validated system in continuous compliance. Savings were uneven by vendor, with the most over provisioned agreements giving back the most.

Which vendors were in scope?

The program covered Oracle database and ULA, SAP ERP and the RISE move, a Microsoft Enterprise Agreement, and a ServiceNow enterprise license renewal, all maturing inside an 18 month window.

Why sequence renewals instead of negotiating them together at once?

Sequencing lets the most flexible vendor close first and establish a benchmark that the other negotiations are measured against. Each closed deal becomes the reference point that compresses the next negotiation.

What evidence anchored the negotiations?

Clean entitlement and deployment records were the central asset. Oracle certification evidence blunted audit pressure, documented usage framed SAP indirect access, deployment data drove Microsoft SKU rightsizing, and an active user audit cut ServiceNow subscription creep.

Does this approach only work for regulated industries?

No. The coordination, evidence, and sequencing lessons transfer to any enterprise with overlapping renewals. The regulatory constraint shaped the leverage here, but the program discipline applies broadly.

When should the evidence base be built?

Begin gathering entitlement and deployment evidence 6 to 9 months before the first renewal. Building it during the program, as happened here, delays the first negotiation and weakens the opening position.